MELK INHIBITION AS A NEW TREATMENT OPTION IN OVARIAN CANCER

被引：0
|
作者：
Kohler, R. [1 ]
Fedier, A. [1 ]
Jacob, F. [1 ]
Heinzelmann-Schwarz, V. [1 ]
机构：
[1] Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2015年 / 25卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ESGO-0353
引用
收藏
页码：623 / 623
页数：1
相关论文
共 50 条
  • [1] Rucaparib: a new treatment option for ovarian cancer
    Sabatucci, Ilaria
    Maltese, Giuseppa
    Lepori, Stefano
    Tripodi, Elisa
    Bogani, Giorgio
    Lorusso, Domenica
    EXPERT OPINION ON PHARMACOTHERAPY, 2018, 19 (07) : 765 - 771
  • [2] 'HYCAMTIN' - New treatment option for ovarian cancer launched
    不详
    IRISH MEDICAL JOURNAL, 1997, 90 (01) : 18 - 18
  • [3] Ovarian Cancer: New Treatment Option for the Relapse Treatment in Platinum-resistant Patients
    Schmale, Ine
    ONCOLOGY RESEARCH AND TREATMENT, 2025, 48 (03)
  • [4] Trabectedin as a New Chemotherapy Option in the Treatment of Relapsed Platinum Sensitive Ovarian Cancer
    Monk, Bradley J.
    Dalton, Heather
    Benjamin, Ivor
    Tanovic, Adnan
    CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (25) : 3754 - 3769
  • [5] Veliparib: a new therapeutic option in ovarian cancer?
    Ghisoni, Eleonora
    Giannone, Gaia
    Tuninetti, Valentina
    Genta, Sofia
    Scotto, Giulia
    Aglietta, Massimo
    Sangiolo, Dario
    Mittica, Gloria
    Valabrega, Giorgio
    FUTURE ONCOLOGY, 2019, 15 (17) : 1975 - 1987
  • [6] VERTEPORFIN, A NEW CHEMOTHERAPEUTIC OPTION IN OVARIAN CANCER
    Dasari, V.
    Smith, A.
    Gogoi, R.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 520 - 520
  • [7] Making the most of every option in the treatment of ovarian cancer
    du Bois, Andreas
    EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 : 1 - 1
  • [8] MELK expression in ovarian cancer correlates with poor outcome and its inhibition by OTSSP167 abrogates proliferation and viability of ovarian cancer cells
    Kohler, Reto S.
    Kettelhack, Henriette
    Knipprath-Meszaros, Alexandra M.
    Fedier, Andre
    Schoetzau, Andreas
    Jacob, Francis
    Heinzelmann-Schwarz, Viola
    GYNECOLOGIC ONCOLOGY, 2017, 145 (01) : 159 - 166
  • [9] Metformin: a new option in cancer treatment
    Belda-Iniesta, Cristobal
    Pernia, Olga
    Simo, Rafael
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2011, 13 (06): : 363 - 367
  • [10] Metformin: a new option in cancer treatment
    Cristóbal Belda-Iniesta
    Olga Pernía
    Rafael Simó
    Clinical and Translational Oncology, 2011, 13 : 363 - 367
12345